WallStreetZenWallStreetZen

NYSEMKT: SER
Serina Therapeutics Inc Earnings & Revenue

SER past earnings growth

How has SER's earnings growth performed historically?
Company
5.2%
Industry
23.46%
Market
127.73%
SER's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SER's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SER's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SER past revenue growth

How has SER's revenue growth performed historically?
Company
410.71%
Industry
90.7%
Market
19.15%
SER's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SER's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SER's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SER earnings and revenue history

Current Revenue
$3.1M
Current Earnings
-$890.1k
Current Profit Margin
-28.3%

SER Return on Equity

Current Company
N/A
Current Industry
16.8%
Current Market
28.2%

Be the first to know when SER announces earnings.

SER Return on Assets

Current Company
-8%
Current Industry
3.2%
SER is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SER Return on Capital Employed

Current Company
41.62%
Current Industry
-42.4%
SER's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SER vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SER$3.15M-$1.03M-$890.15k+15.30%+5.20%
CVM$0.00-$25.22M-$29.95M-100.00%N/A
MAIA$0.00-$23.72M-$23.72MN/AN/A
MRNS$28.29M-$129.08M-$145.34M+191.54%N/A
GRTS$15.65M-$117.74M-$144.89M+43.92%N/A

SER earnings dates

Next earnings date
Aug 6, 2024

Serina Therapeutics Earnings & Revenue FAQ

What were SER's earnings last quarter?

On Invalid Date, Serina Therapeutics (NYSEMKT: SER) reported Q1 2024 earnings per share (EPS) of -$3.38, up 538.96% year over year. Total Serina Therapeutics earnings for the quarter were -$9.44 million. In the same quarter last year, Serina Therapeutics's earnings per share (EPS) was $0.77.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.

What was SER's earnings growth in the past year?

As of Q3 2024, Serina Therapeutics's earnings has grown 5.2% year over year. This is 18.26 percentage points lower than the US Biotechnology industry earnings growth rate of 23.46%. Serina Therapeutics's earnings in the past year totalled -$890.15 thousand.

What is SER's earnings date?

Serina Therapeutics's earnings date is Invalid Date. Add SER to your watchlist to be reminded of SER's next earnings announcement.

What was SER's revenue last quarter?

On Invalid Date, Serina Therapeutics (NYSEMKT: SER) reported Q1 2024 revenue of $5.00 thousand up 83.33% year over year. In the same quarter last year, Serina Therapeutics's revenue was $30.00 thousand.

What was SER's revenue growth in the past year?

As of Q3 2024, Serina Therapeutics's revenue has grown 410.71% year over year. This is 320 percentage points higher than the US Biotechnology industry revenue growth rate of 90.7%. Serina Therapeutics's revenue in the past year totalled $3.15 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.